Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN
- PMID: 26567243
- PMCID: PMC4849835
- DOI: 10.1681/ASN.2015060612
Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN
Abstract
Renal pathologists and nephrologists met on February 20, 2015 to establish an etiology/pathogenesis-based system for classification and diagnosis of GN, with a major aim of standardizing the kidney biopsy report of GN. On the basis of etiology/pathogenesis, GN is classified into the following five pathogenic types, each with specific disease entities: immune-complex GN, pauci-immune GN, antiglomerular basement membrane GN, monoclonal Ig GN, and C3 glomerulopathy. The pathogenesis-based classification forms the basis of the kidney biopsy report. To standardize the report, the diagnosis consists of a primary diagnosis and a secondary diagnosis. The primary diagnosis should include the disease entity/pathogenic type (if disease entity is not known) followed in order by pattern of injury (mixed patterns may be present); score/grade/class for disease entities, such as IgA nephropathy, lupus nephritis, and ANCA GN; and additional features as detailed herein. A pattern diagnosis as the sole primary diagnosis is not recommended. Secondary diagnoses should be reported separately and include coexisting lesions that do not form the primary diagnosis. Guidelines for the report format, light microscopy, immunofluorescence microscopy, electron microscopy, and ancillary studies are also provided. In summary, this consensus report emphasizes a pathogenesis-based classification of GN and provides guidelines for the standardized reporting of GN.
Keywords: glomerulonephritis; kidney biopsy; renal biopsy.
Copyright © 2016 by the American Society of Nephrology.
Comment in
- 1265–1266
Similar articles
-
Standardized classification and reporting of glomerulonephritis.Nephrol Dial Transplant. 2019 Feb 1;34(2):193-199. doi: 10.1093/ndt/gfy220. Nephrol Dial Transplant. 2019. PMID: 30124958 Review.
-
Etiology and Outcome of Crescentic Glomerulonephritis From a Single Center in China: A 10-Year Review.Am J Kidney Dis. 2016 Mar;67(3):376-83. doi: 10.1053/j.ajkd.2015.07.034. Epub 2015 Sep 19. Am J Kidney Dis. 2016. PMID: 26388283
-
Etiology-based diagnostic approach to proliferative glomerulonephritis.Am J Kidney Dis. 2014 Apr;63(4):561-6. doi: 10.1053/j.ajkd.2013.11.019. Epub 2013 Dec 31. Am J Kidney Dis. 2014. PMID: 24387793
-
Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases.Adv Anat Pathol. 2012 Mar;19(2):111-24. doi: 10.1097/PAP.0b013e318248b7a1. Adv Anat Pathol. 2012. PMID: 22313839 Review.
-
C4d as a Diagnostic Tool in Proliferative GN.J Am Soc Nephrol. 2015 Nov;26(11):2852-9. doi: 10.1681/ASN.2014040406. Epub 2015 May 19. J Am Soc Nephrol. 2015. PMID: 25991041 Free PMC article.
Cited by
-
Membranoproliferative Glomerulonephritis over 20 Years at a Tertiary Referral Center in the UK.Glomerular Dis. 2024 Aug 2;4(1):159-166. doi: 10.1159/000540672. eCollection 2024 Jan-Dec. Glomerular Dis. 2024. PMID: 39473993 Free PMC article.
-
A Novel Integrated Pipeline for Site-Specific Quantification of N-glycosylation.Phenomics. 2024 Apr 10;4(3):213-226. doi: 10.1007/s43657-023-00150-w. eCollection 2024 Jun. Phenomics. 2024. PMID: 39398429
-
HEV ORF2 protein-antibody complex deposits are associated with glomerulonephritis in hepatitis E with reduced immune status.Nat Commun. 2024 Oct 14;15(1):8849. doi: 10.1038/s41467-024-53072-0. Nat Commun. 2024. PMID: 39397005 Free PMC article.
-
Minimal change glomerular disease associated with solid neoplasms: a systematic review.J Nephrol. 2024 Oct 1. doi: 10.1007/s40620-024-02084-6. Online ahead of print. J Nephrol. 2024. PMID: 39352607 Review.
-
The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns.J Transl Med. 2024 Aug 16;22(1):773. doi: 10.1186/s12967-024-05578-w. J Transl Med. 2024. PMID: 39152439 Free PMC article.
References
-
- Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D’Agati V, D’Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society : The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification. Kidney Int 76: 534–545, 2009 - PubMed
-
- Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi L-M, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241–250, 2004 - PubMed
-
- Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D’Agati VD: Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features. Kidney Int 63: 1450–1461, 2003 - PubMed
-
- Alpers CE, Kowalewska J: Fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 19: 34–37, 2008 - PubMed
-
- Zand L, Fervenza FC, Nasr SH, Sethi S: Membranoproliferative glomerulonephritis associated with autoimmune diseases. J Nephrol 27: 165–171, 2014 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
